drugset / Trial / NCT03638726

Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification

NCT03638726

Phase 4 Unknown 40 enrolled Dar El Oyoun Hospital
RandomizedParallel-groupSingle-blindOther

Summary

Mydriatic eye drops are routinely used before phacoemulsification but they are not free of drawbacks. Several alternatives were tried to overcome their limitations.

Timeline

Start
2018-09-28
Primary completion
2019-03
Completion
2019-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 0.6 mg Other
Subject Epinephrine Other / unclassified Other
Subject Phenylephrine Small molecule
Subject cyclopentolate Unknown

Indications